US$ 23.89
clinicaltrials.gov bpc 157 Multifunctionality and Possible Medical Application of the Peptide—Literature and Patent Review Heal or Harm: Body Protective
Description
, torsades de pointes (, , , , , , , , , , ): , ,

Phase 2 dominates growth : Phase 2 trials jumped significantly from 1,711 (2024) to 2,278 (2025), the highest level ever seenmaking Phase 2 the primary growth engine

~ AlphaMD You've probably heard the locker room talk

PMID: 35337625

Random timing wastes efficacy